Weiqian Li

409 citations
19 papers · 294 indexed · h-index 9
Topics
Immune Cell Function and Interaction (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)Immune cells in cancer (4 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Weiqian Li

18 papers receiving 292 citations

Peers

Weiqian Li
Comparison fields: 5 of 68
  • Molecular Biology 190
  • Cancer Research 118
  • Immunology 53
  • Oncology 52
  • Pulmonary and Respiratory Medicine 27
Replace Youxiang Mao with:
Youxiang Mao China
Minyu Chen China
Jianli Zhang China
Jason Mighty United States
Fengtian Li China
Yun Cheng China
Tai-Shan Cheng Taiwan
Shihao Wang China
Yao Xu China
Bárbara González‐Terán United States
Weiqian Li relative to Youxiang Mao China Youxiang Mao's profile →
Citations per field
00.5×2.6×
Youxiang Mao · 1×
Citations per year

Countries citing papers authored by Weiqian Li

Since Specialization
Citations

This map shows the geographic impact of Weiqian Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiqian Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiqian Li more than expected).

Fields of papers citing papers by Weiqian Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiqian Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiqian Li. The network helps show where Weiqian Li may publish in the future.

Co-authorship network of co-authors of Weiqian Li

This figure shows the co-authorship network connecting the top 25 collaborators of Weiqian Li. A scholar is included among the top collaborators of Weiqian Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiqian Li. Weiqian Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 0
2 2
3 8
4 10
5 1
6 1
7 6
8 8
9 8
10 11
11 21
12 9
13 7
14 41
15 26
16 18
17 32
18 84
19
Resarch on the effect of Fufang Xiyi San different particle combination agent on intervention Wnt pathway in precancerous lesions of gastric cancer model rats
1

About Weiqian Li

Weiqian Li is a scholar working on Biological Psychiatry, Cancer Research and Immunology, having authored 19 papers that have together received 294 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Cancer Research (118 citations), Biological Psychiatry (9 citations) and Molecular Biology (190 citations). Weiqian Li has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Xiangling Yang, Huanliang Liu, Junxiong Chen, Lan Huang, Ruixian Liu, Chuangyu Wen, Ka‐Wo Chan, Lili Wei, Mengmeng Lin and Jingdan Zhang. Their work appears in journals such as British Journal of Cancer, Optics Express and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026